-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KZ4vb4X+Ut3j+BIJrwIqyZqs+cqvHAsxWpFdzeji1t9fb6rJPZYoAR6XBv4zlcZK EZqb2QYUs7qfC3//5ge6YA== 0000889812-98-001840.txt : 19980803 0000889812-98-001840.hdr.sgml : 19980803 ACCESSION NUMBER: 0000889812-98-001840 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980730 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANGEION CORP/MN CENTRAL INDEX KEY: 0000815093 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411579150 STATE OF INCORPORATION: MN FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-40187 FILM NUMBER: 98674095 BUSINESS ADDRESS: STREET 1: 7601 NORTHLAND DRIVE STREET 2: STE 170 CITY: BROOKLYN PARK STATE: MN ZIP: 55428 BUSINESS PHONE: 6125509388 MAIL ADDRESS: STREET 1: 7601 NORTHLAND DRIVE STREET 2: SUITE 170 CITY: BROOKLYN PARK STATE: MN ZIP: 55428 FORMER COMPANY: FORMER CONFORMED NAME: VERDE VENTURES INC DATE OF NAME CHANGE: 19880714 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SYNTHELABO CENTRAL INDEX KEY: 0001051557 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 22 AVENUE GALILEE STREET 2: 92350 LE PLESSIS ROBINSON CITY: FRANCE STATE: I0 ZIP: 00000 SC 13D/A 1 AMENDEMENT NO.1 Page 1 of 4 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Angeion Corporation (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 03462H 10 7 (CUSIP Number) James C. Colihan, Esq. Coudert Brothers 1114 Avenue of the Americas New York, NY 10036 (212) 626-4400 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Not Applicable (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box |_|. Page 2 of 4 Pages This Amendment No. 1 to the Schedule 13D, dated December 19, 1997 (the "Schedule 13D"), filed by Synthelabo with the Securities and Exchange Commission with respect to the Common Stock, par value $.01 per share, of Angeion Corporation, is being filed to amend Item 7 (Materials to Be Filed as Exhibits) of the Schedule 13D to amend and add to the Exhibits being incorporated by reference therein. Item 7 of the Schedule 13D is hereby amended to read in its entirety as follows: Item 7. Materials to Be Filed as Exhibits. 1. Amended and Restated Investment and Master Strategic Relationship Agreement between Synthelabo and Angeion Corporation, dated as of October 9, 1997, together with Exhibits A-1, A-2, A-3, A-4, A-5, B, C, D, G and H thereto and Side Letter between Angeion Corporation and Synthelabo dated as of December 9, 1997. The foregoing Exhibits are incorporated herein by reference to Exhibits 10.1, 10.7, 10.8, 10.9, 10.10, 10.11, 10.3, 10.2, 10.4, 10.5, 10.6 and 10.14, respectively, filed as part of Angeion Corporation's Form 10-Q/A to its Quarterly Report on Form 10-Q for the quarterly period ended October 31, 1997, which Form 10-Q/A was filed with the Securities and Exchange Commission on July 29, 1998. [remainder of page intentionally blank] Page 3 of 4 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: July 30, 1998 SYNTHELABO By: /s/ Pierre Lepienne Name: Pierre Lepienne Title: Executive Vice President Member of the Board Page 4 of 4 Pages EXHIBIT INDEX
Exhibit Page Number - ------ ----------- 1. Amended and Restated Investment and Master Incorporated by reference to Strategic Relationship Agreement, between Exhibits 10.1, 10.7, 10.8, Synthelabo and Angeion Corporation, dated as 10.9, 10.10, 10.11, 10.3, of October 9, 1997, together with Exhibits 10.2, 10.4, 10.5, 10.6 and A-1, A-2, A-3, A-4, A-5, B, C, D, G and H 10.14, respectively, to Angeion thereto and Side Letter between Angeion Corporation's Form 10-Q/A to its Corporation and Synthelabo dated as of Quarterly Report on Form 10-Q for December 9, 1997.* the quartelry period ended October 31, 1997, which Form 10-Q/A was filed with the Securities and Exchange Commission on July 29, 1998.
- ------------------------ * Portions of certain of the exhibits have been omitted, as indicated therein, pursuant to requests for confidential treatment by Angeion Corporation and Synthelabo. -----END PRIVACY-ENHANCED MESSAGE-----